Back to search
Post-acute Infectious Syndrome (PAIS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-acute Infectious Syndrome (PAIS) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-acute Infectious Syndrome (PAIS) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Post-acute infection syndromes (PAIS) are long-lasting health problems that can develop after an infection. They include post-COVID-19 syndrome and similar illn…
Post-acute infectious syndrome (PAIS), including post-COVID-19 condition (PCC or Long COVID), can develop after an infection and may cause persistent symptoms s…
RECLAIM is a Phase III, multi-domain, randomized, controlled, adaptive platform trial, designed to evaluate efficacy and safety of repurposed medications in pat…